Valuation — not yet established
No valuation for ONL Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($132.5M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 10 rounds
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for ONL Therapeutics
Create free account
No card required
Funding history
10 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2024 | Later Stage VC | $60.0M | ▮ | ▮ |
| Feb 2024 | Early Stage VC | $10.0M | ▮ | ▮ |
| Mar 2023 | Seed Round | $5.0M | ▮ | ▮ |
| Dec 2020 | Early Stage VC | $26.8M | ▮ | ▮ |
| Oct 2020 | Seed Round | $2.0M | ▮ | ▮ |
| Aug 2019 | Seed Round | $3.0M | ▮ | ▮ |
| + 4 earlier rounds · a free account shows the full history | ||||
How ONL Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For ONL Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has ONL Therapeutics raised?
- ONL Therapeutics has raised $132.5M in total funding across 10 recorded rounds.
- When did ONL Therapeutics last raise?
- ONL Therapeutics last raised in Sep 2024 (Later Stage VC), raising $60.0M.